Stocks to Watch: vTv Therapeutics, BJ's Restaurants, Warner Bros. Discovery

Dow Jones07-27

By Connor Hart

The Food and Drug Administration placed a clinical hold on vTv Therapeutics' program studying a treatment for Type 1 diabetes. The diabetes-focused biopharmaceutical company on Friday said the decision came after the discovery of a chromatographic signal in a recent human study of how the treatment was absorbed, distributed, metabolized and excreted couldn't be resolved by standard mass spectroscopy. Shares tumble 39%, to $12.90, in after-hours trading.

BJ's Restaurants posted a dip in same-store sales in the second quarter. Despite a 0.6% drop in comparable sales, the company's recent earnings beat analysts' expectations. The casual-dining company on Thursday after the bell posted per-share earnings of 72 cents, beating the 54 cents expected by analysts polled by FactSet. Shares fell more than 15% during market trading Friday, to $31.51, before rebounding slightly in postmarket trading.

Warner Bros. Discovery on Friday filed a breach of contract suit against the National Basketball Association after the league this week passed over its last-minute bid to keep basketball games on its TNT network. Warner, which sought to exercise a clause in its contract allowing it to match rival bids, alleged the league violated a media-rights agreement by striking a deal with Amazon.com's Prime Video.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

July 26, 2024 19:00 ET (23:00 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2454301055?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-27 07:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2454301055","market":"sh","top_or_hot":-1,"title":"Stocks to Watch: vTv Therapeutics, BJ's Restaurants, Warner Bros. Discovery","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  The Food and Drug Administration placed a clinical hold on vTv <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>' program studying a treatment for Type 1 diabetes. The diabetes-focused biopharmaceutical company on Friday said the decision came after the discovery of a chromatographic signal in a recent human study of how the treatment was absorbed, distributed, metabolized and excreted couldn't be resolved by standard mass spectroscopy. Shares tumble 39%, to $12.90, in after-hours trading. \n</p>\n<p>\n  BJ's Restaurants posted a dip in same-store sales in the second quarter. Despite a 0.6% drop in comparable sales, the company's recent earnings beat analysts' expectations. The casual-dining company on Thursday after the bell posted per-share earnings of 72 cents, beating the 54 cents expected by analysts polled by FactSet. Shares fell more than 15% during market trading Friday, to $31.51, before rebounding slightly in postmarket trading. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/WBD\">Warner Bros. Discovery</a> on Friday filed a breach of contract suit against the National Basketball Association after the league this week passed over its last-minute bid to keep basketball games on its TNT network. Warner, which sought to exercise a clause in its contract allowing it to match rival bids, alleged the league violated a media-rights agreement by striking a deal with Amazon.com's Prime Video. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 26, 2024 19:00 ET (23:00 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks to Watch: vTv Therapeutics, BJ's Restaurants, Warner Bros. Discovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks to Watch: vTv Therapeutics, BJ's Restaurants, Warner Bros. Discovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-27 07:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Connor Hart \n\n\n \n\n\n  The Food and Drug Administration placed a clinical hold on vTv Therapeutics' program studying a treatment for Type 1 diabetes. The diabetes-focused biopharmaceutical company on...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2454301055","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2454301055","pubTimestamp":1722034800,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"The Food and Drug Administration placed a clinical hold on vTv Therapeutics' program studying a treatment for Type 1 diabetes. The diabetes-focused biopharmaceutical company on Friday said the decision came after the discovery of a chromatographic signal in a recent human study of how the treatment was absorbed, distributed, metabolized and excreted couldn't be resolved by standard mass spectroscopy. Shares tumble 39%, to $12.90, in after-hours trading.BJ's Restaurants posted a dip in same-store sales in the second quarter. Despite a 0.6% drop in comparable sales, the company's recent earnings beat analysts' expectations. The casual-dining company on Thursday after the bell posted per-share earnings of 72 cents, beating the 54 cents expected by analysts polled by FactSet. Shares fell more than 15% during market trading Friday, to $31.51, before rebounding slightly in postmarket trading.Warner Bros. Discovery on Friday filed a breach of contract suit against the National Basketball Asso","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4108":"电影和娱乐","BK4585":"ETF&股票定投概念","BK4125":"广播","VTVT":"vTv Therapeutics Inc.","BK4155":"大卖场与超市","BJ":"BJ批发俱乐部","WBD":"Warner Bros. Discovery","BK4588":"碎股","BK4209":"餐馆","BJRI":"BJs餐饮"},"translate_title":"值得关注的股票：vTv Therapeutics、BJ's Restaurants、Warner Bros.Discovery","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BJ":1,"BJRI":1,"VTVT":1,"WBD":1},"content_text":"By Connor Hart \n\n\n \n\n\n  The Food and Drug Administration placed a clinical hold on vTv Therapeutics' program studying a treatment for Type 1 diabetes. The diabetes-focused biopharmaceutical company on Friday said the decision came after the discovery of a chromatographic signal in a recent human study of how the treatment was absorbed, distributed, metabolized and excreted couldn't be resolved by standard mass spectroscopy. Shares tumble 39%, to $12.90, in after-hours trading. \n\n\n  BJ's Restaurants posted a dip in same-store sales in the second quarter. Despite a 0.6% drop in comparable sales, the company's recent earnings beat analysts' expectations. The casual-dining company on Thursday after the bell posted per-share earnings of 72 cents, beating the 54 cents expected by analysts polled by FactSet. Shares fell more than 15% during market trading Friday, to $31.51, before rebounding slightly in postmarket trading. \n\n\nWarner Bros. Discovery on Friday filed a breach of contract suit against the National Basketball Association after the league this week passed over its last-minute bid to keep basketball games on its TNT network. Warner, which sought to exercise a clause in its contract allowing it to match rival bids, alleged the league violated a media-rights agreement by striking a deal with Amazon.com's Prime Video. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 26, 2024 19:00 ET (23:00 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2454301055"}